Evidence map›Paper›PMID 42016578›Full record

ArticleFrontiers in psychiatry2026

Psychometric validation of the Polish version of the Utrecht Gender Dysphoria Scale - Gender Spectrum questionnaire.

Agata Tokarek, Aleksandra Koczut, Agata Gasiorowska

Abstract read
In one paragraph

Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Agata TokarekFaculty of Psychology in Wroclaw, SWPS University, Wroclaw, Poland.
Aleksandra KoczutFaculty of Psychology in Wroclaw, SWPS University, Wroclaw, Poland.
Agata GasiorowskaFaculty of Psychology in Wroclaw, SWPS University, Wroclaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Accessible and inclusive tools for assessing gender dysphoria in Polish-speaking populations remain limited. To bridge this gap in care, there is an urgent need for accessible, psychometrically sound tools to assess Polish gender-diverse individuals. In this study, we aimed to adapt the Polish version of the Utrecht Gender Dysphoria Scale - Gender Spectrum to address a critical gap in assessment tools that include nonbinary, binary transgender, and cisgender individuals. Methods: In Study 1 (N = 1,057), the 18-item UGDS-GS was translated into Polish using a backward translation procedure. Its factorial structure, internal consistency, and construct validity were examined in an online sample of Polish adults, including binary transgender, nonbinary, and cisgender participants recruited via social media and the Prolific platform between July and August 2025. Participants completed the UGDS-GS along with measures of anxiety, depression, and gender dysphoria. In Study 2, an independent sample of Polish adults (N = 245 at T1) recruited via Prolific completed the UGDS-GS-PL. Additional confirmatory factor analyses were conducted, and stability over time was assessed using a three-week test-retest design. Results: Confirmatory factor analysis did not support the original two-factor structure. Exploratory factor analysis instead identified a three-factor solution Conclusions: The scale provides a valuable alternative to existing binary-focused instruments and demonstrates that gender-neutral assessment of gender dysphoria is both feasible and psychologically viable in the Polish language.

Indexed as

gender dysphoriagender identitypsychometricssurveys and questionnairestransgender persons

Identifiers

PMID42016578
PMCPMC13093971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.